207 related articles for article (PubMed ID: 10436095)
41. A systems approach to immediate evaluation and management of hyperacute stroke. Experience at eight centers and implications for community practice and patient care. The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group.
Stroke; 1997 Aug; 28(8):1530-40. PubMed ID: 9259745
[TBL] [Abstract][Full Text] [Related]
42. Agreement Among Stroke Faculty and Fellows in Treating Ischemic Stroke Patients With Tissue-Type Plasminogen Activator and Thrombectomy.
Ramadan AR; Denny MC; Vahidy F; Yamal JM; Wu TC; Sarraj A; Savitz S; Grotta J
Stroke; 2017 Jan; 48(1):222-224. PubMed ID: 27879445
[TBL] [Abstract][Full Text] [Related]
43. Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator.
Manelfe C; Larrue V; von Kummer R; Bozzao L; Ringleb P; Bastianello S; Iweins F; Lesaffre E
Stroke; 1999 Apr; 30(4):769-72. PubMed ID: 10187877
[TBL] [Abstract][Full Text] [Related]
44. Computed tomographic findings in patients undergoing intra-arterial thrombolysis for acute ischemic stroke due to middle cerebral artery occlusion: results from the PROACT II trial.
Roberts HC; Dillon WP; Furlan AJ; Wechsler LR; Rowley HA; Fischbein NJ; Higashida RT; Kase C; Schulz GA; Lu Y; Firszt CM
Stroke; 2002 Jun; 33(6):1557-65. PubMed ID: 12052991
[TBL] [Abstract][Full Text] [Related]
45. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study.
IMS Study Investigators
Stroke; 2004 Apr; 35(4):904-11. PubMed ID: 15017018
[TBL] [Abstract][Full Text] [Related]
46. The Interventional Management of Stroke (IMS) II Study.
IMS II Trial Investigators
Stroke; 2007 Jul; 38(7):2127-35. PubMed ID: 17525387
[TBL] [Abstract][Full Text] [Related]
47. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.
del Zoppo GJ; Higashida RT; Furlan AJ; Pessin MS; Rowley HA; Gent M
Stroke; 1998 Jan; 29(1):4-11. PubMed ID: 9445320
[TBL] [Abstract][Full Text] [Related]
48. Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke.
Heiss WD; Grond M; Thiel A; von Stockhausen HM; Rudolf J; Ghaemi M; Löttgen J; Stenzel C; Pawlik G
J Cereb Blood Flow Metab; 1998 Dec; 18(12):1298-307. PubMed ID: 9850142
[TBL] [Abstract][Full Text] [Related]
49. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.
Tanne D; Kasner SE; Demchuk AM; Koren-Morag N; Hanson S; Grond M; Levine SR
Circulation; 2002 Apr; 105(14):1679-85. PubMed ID: 11940547
[TBL] [Abstract][Full Text] [Related]
50. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke.
Kim DH; Lee DS; Nah HW; Cha JK
BMC Neurol; 2018 Mar; 18(1):30. PubMed ID: 29544461
[TBL] [Abstract][Full Text] [Related]
51. Delayed increase in infarct volume after cerebral ischemia: correlations with thrombolytic treatment and clinical outcome.
Pantano P; Caramia F; Bozzao L; Dieler C; von Kummer R
Stroke; 1999 Mar; 30(3):502-7. PubMed ID: 10066843
[TBL] [Abstract][Full Text] [Related]
52. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
[TBL] [Abstract][Full Text] [Related]
53. The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators.
Clark WM; Albers GW; Madden KP; Hamilton S
Stroke; 2000 Apr; 31(4):811-6. PubMed ID: 10753980
[TBL] [Abstract][Full Text] [Related]
54. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
[TBL] [Abstract][Full Text] [Related]
55. Rupture of an Occult Intracranial Mycotic Aneurysm after Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke.
Glenn J; Strecker-McGraw M; McGraw I; Jabbar K; James NA; Stone CK
J Emerg Med; 2017 Nov; 53(5):717-721. PubMed ID: 28988732
[TBL] [Abstract][Full Text] [Related]
56. [ASPECTS-DWI, arterial occlusion sites and subtype of acute ischemic stroke have a relation with outcome following intravenous rt-PA therapy].
Idei M; Sasaki T; Tanabe T; Muraoka K; Terada K; Meguro T; Hirotsune N; Nishino S
No Shinkei Geka; 2012 Jul; 40(7):585-91. PubMed ID: 22728535
[TBL] [Abstract][Full Text] [Related]
57. Agreement in endovascular thrombolysis patient selection based on interpretation of presenting CT and CT-P changes in ischemic stroke patients.
Hassan AE; Zacharatos H; Chaudhry SA; Suri MF; Rodriguez GJ; Miley JT; Maud A; Taylor RA; Ezzeddine MA; Anderson DC; Qureshi AI
Neurocrit Care; 2012 Feb; 16(1):88-94. PubMed ID: 21725693
[TBL] [Abstract][Full Text] [Related]
58. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
[TBL] [Abstract][Full Text] [Related]
59. Intravenous thrombolytic therapy for stroke: a review of recent studies and controversies.
Osborn TM; LaMonte MP; Gaasch WR
Ann Emerg Med; 1999 Aug; 34(2):244-55. PubMed ID: 10424932
[TBL] [Abstract][Full Text] [Related]
60. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice.
Chiu D; Krieger D; Villar-Cordova C; Kasner SE; Morgenstern LB; Bratina PL; Yatsu FM; Grotta JC
Stroke; 1998 Jan; 29(1):18-22. PubMed ID: 9445322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
